Are you looking for expert advice...
Course Content
Learning Objectives
0/1
Introduction & Learning Objectives
01:17
Curriculum
0/15
Myth 1: “Recreational cannabis is the same as medical cannabis.”
03:12
Myth 2: “Over-the-counter CBD is a medicine.”
03:42
Myth 3: “Minor cannabinoids and terpenes don’t matter.”
01:22
Myth 4: “Medical cannabis can only be prescribed for a few conditions.”
01:01
Myth 5: “Medical cannabis is not available on the NHS”
00:58
Myth 6: “The higher the THC, the better the medicine”
01:28
Myth 7: “Cannabis causes psychosis”
00:51
Myth 8: “Medical cannabis precipitates or worsens addiction”
02:26
Myth 9: “Only certain consultants can prescribe medical cannabis”
00:54
Myth 10: “We can’t discuss medical cannabis with our NHS patients”
01:39
Myth 11: “Flowers need to have recreational names.”
01:18
Myth 12: “You can’t use medical cannabis in public”
01:25
Myth 13: “Patients must have tried two licensed medicines first”
00:45
Key Takeaways
00:29
Quiz
Protected: Myths, Questions and Challenges: Addressing Common Conversations in Medical Cannabis Prescribing (Copy 1)

By the end of this course, participants will be able to:

  • Differentiate between medical and recreational cannabis, including key differences in cultivation, regulation, and product safety.

  • Explain the purpose and implications of irradiation for medical cannabis products and identify when non-irradiated products may pose risks.

  • Describe the various CBD product types (full spectrum, broad spectrum, isolate, etc.) and their differences in clinical relevance and entourage effect.

  • Recognise the importance of minor cannabinoids and terpenes in patient response and therapeutic outcomes.

  • Clarify misconceptions around prescribing limitations and communicate evidence-based information about the range of conditions medical cannabis may support.

  • Respond confidently to common myths and questions from patients and peers using factual, regulatory, and evidence-based information.

  • Apply professional judgement and informed consent principles when patients request non-standard formulations or products.

Previous
Next